logo
logo

Atopia Therapeutics Appoints Dr. Grégoire Chevalier As Chief Executive Officer

May 07, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Atopia Therapeutics

Dr. Grégoire Chevalier
GenevaTherapeuticsBiotechnologyHealth Care

Description

Atopia Therapeutics, formerly known as HpVac, has appointed Dr. Grégoire Chevalier as the new chief executive officer (CEO). The company has repositioned itself to better reflect its commitment to addressing the growing global burden of atopic diseases.

Company Information

Company

Atopia Therapeutics

Location

Geneva, Geneva, Switzerland

About

Atopia Therapeutics is focused on the development of a preventive and therapeutic first-line therapy against asthma, eczema, food allergies and related allergic diseases.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months